Ito, Sadayoshi

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 1,880

Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome

Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences

Peroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

Cited by 832

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes

Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 792

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

Tangri, N., Grams, M. E., Levey, A. S., Coresh, J., Appel, L. J., Astor, B. C., Chodick, G., Collins, A. J., Djurdjev, O., Elley, C. R., et al. (2016) · JAMA

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 737

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Heerspink, H. J. L., Greene, T., Tighiouart, H., Gansevoort, R. T., Coresh, J., Simon, A. L., Chan, T. M., Hou, F. F., Lewis, J. B., Locatelli, F., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 397

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

Writing Group for the CKD Prognosis Consortium, Appel, L. J., Grams, M., Woodward, M., Harris, K., Arima, H., Chalmers, J., Yatsuya, H., Tamakoshi, K., Li, Y., et al. (2023) · JAMA

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 396

Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma

Kimura, N., Takayanagi, R., Takizawa, N., Itagaki, E., Katabami, T., Kakoi, N., Rakugi, H., Ikeda, Y., Tanabe, A., Nigawara, T., et al. (2014) · Endocrine Related Cancer

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 393

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study

for the ORIENT study investigators, Imai, E., Chan, J. C. N., Ito, S., Yamasaki, T., Kobayashi, F., Haneda, M., & Makino, H. (2011) · Diabetologia

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 236

Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial

Ito, S., Kashihara, N., Shikata, K., Nangaku, M., Wada, T., Okuda, Y., & Sawanobori, T. (2020) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 234

Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes

Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S., & for the INNOVATION Study Group (2007) · Diabetes Care

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 230

Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas

MORIMOTO, R., SATOH, F., MURAKAMI, O., SUZUKI, T., ABE, T., TANEMOTO, M., ABE, M., URUNO, A., ISHIDOYA, S., ARAI, Y., et al. (2008) · Endocrine Journal

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 141

Conformational Change in Transfer RNA Is an Early Indicator of Acute Cellular Damage

Mishima, E., Inoue, C., Saigusa, D., Inoue, R., Ito, K., Suzuki, Y., Jinno, D., Tsukui, Y., Akamatsu, Y., Araki, M., et al. (2014) · Journal of the American Society of Nephrology

RNA modifications and cancerAcute Kidney Injury Research

Cited by 112

Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Ito, S., Shikata, K., Nangaku, M., Okuda, Y., & Sawanobori, T. (2019) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 107

Immunoreactive orexin-A in human plasma

Arihara, Z., Takahashi, K., Murakami, O., Totsune, K., Sone, M., Satoh, F., Ito, S., & Mouri, T. (2001) · Peptides

Sleep and Wakefulness ResearchNeuropeptides and Animal Physiology

Cited by 101

Development of sensitive derivatization method for aldosterone in liquid chromatography–electrospray ionization tandem mass spectrometry of corticosteroids

Yamashita, K., Okuyama, M., Nakagawa, R., Honma, S., Satoh, F., Morimoto, R., Ito, S., Takahashi, M., & Numazawa, M. (2008) · Journal of Chromatography A

Mass Spectrometry Techniques and ApplicationsAnalytical Methods in Pharmaceuticals

Cited by 57

ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration

Hirose, T., Cabrera-Socorro, A., Chitayat, D., Lemonnier, T., Féraud, O., Cifuentes-Diaz, C., Gervasi, N., Mombereau, C., Ghosh, T., Stoica, L., et al. (2019) · Journal of Clinical Investigation

ATP Synthase and ATPases ResearchAutophagy in Disease and Therapy

Cited by 55

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features

Saito, T., Oikawa, S., Sato, H., Sato, T., Ito, S., & Sasaki, J. (1999) · Kidney International

Renal Diseases and GlomerulopathiesLipid metabolism and disorders

Cited by 37

Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes

Ogawa, S., Abe, T., Nako, K., Okamura, M., Senda, M., Sakamoto, T., Ito, S., & the DIMS study group (2013) · The Tohoku Journal of Experimental Medicine

Fatty Acid Research and HealthDiabetes Treatment and Management

Cited by 22

Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance

Fujita, H., Narita, T., & Ito, S. (1999) · Diabetes Care

Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

Cited by 17

Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis

Nakayama, K., Natori, Y., Sato, T., Kimura, T., Sugiura, A., Sato, H., Saito, T., Ito, S., & Natori, Y. (2004) · Journal of Laboratory and Clinical Medicine

Renal Diseases and GlomerulopathiesProteoglycans and glycosaminoglycans research

Cited by 11